Report : A-Z NHS England items in Formulary 24/04/2025 20:25:13

[Back]

Section Status NHS England Name 19 Formulary ​Holmium-166 microsphere QuiremSpheres® 08.01.05 Formulary Acalabrutinib Calquence® 08.01.05 Formulary Afatinib   08.01.05 Formulary Alectinib Alecensa® 08.02.03 Formulary Alemtuzumab  08.03.04.01 Formulary Alpelisib Piqray® 08.01.05 Formulary Asciminib Scemblix® 09.08.01 Formulary Asfotase alfa Strensiq® 08.01.05 Formulary Atezolizumab  09.08.01 Formulary Avalglucosidase alfa Nexviadyme® 08.01.05 Formulary Avapritinib Ayvakyt® 08.02.03 Formulary Avelumab Bavencio® 08.01.05 Formulary Axicabtagene ciloleucel  08.01.05 Formulary Axitinib  Inlyta® 08.02.02 Formulary Belumosudil Rezurock® 08.01.05 Formulary Belzutifan Welireg® 03.04.02 Formulary Benralizumab Fasenra® 05.03.01 Formulary Bictegraivr/emtricitabine/tenofovir alafenamide Biktarvy® 08.01.05 Formulary Bortezomib   08.01.05 Formulary Bosutinib Bosulif® 08.01.05 Formulary Brexucabtagene autoleucel Tecartus® 08.01.05 Formulary Brigatinib Alunbrig® 05.03.03.02 Formulary Bulevirtide Hepcludex® 06.06.02 Formulary Burosumab  Crysvita® 03.04.03 Formulary C1 Esterase Inhibitor  08.01.05 Formulary Cabozantinib Cometriq® 04.06 Formulary Cannabidiol  Epidyolex® 04.08.01 Formulary Cannabidiol Epidyolex® 08.01.05 Formulary Carfilzomib Kyprolis® 08.01.05 Formulary Cemiplimab Libtayo® 08.01.05 Formulary Ceritinib   08.01.05 Formulary Chlormethine Gel  09.01.03 Formulary Crovalimab Piasky® 08.01.05 Formulary Dabrafenib  Tafinlar® 05.03.03.02 Formulary Daclatasvir   08.01.05 Formulary Dacomitinib Vizimpro® 09.01.03 Formulary Danicopan Voydeya® 08.01.05 Formulary Daratumumab Darzalex® 08.03.04.02 Formulary Darolutamide Nubeqa® 08.01.03 Formulary Daunorubicin/cytarabine Vyxeos® 13.14.07 Formulary Difelikefalin Kapruvia® 08.02.04 Formulary Dimethyl fumarate Tecfidera® 08.01.05 Formulary Dinutuximab beta Qarziba® 08.02.04 Formulary Diroximel fumarate Vumerity® 05.03.01 Formulary Dolutegravir Sodium & Lamivudine Dovato® 05.03.01 Formulary Dolutegravir Sodium & Rilpivirine Hydrochloride Juluca® 08.01.05 Formulary Dostarlimab  Jemperli 03.04.02 Formulary Dupilumab Dupixent® 13.05.03 Formulary Dupilumab Dupixent® 13.05.03 Non Formulary Dupilumab Dupixent® 08.01.05 Formulary Durvalumab Imfinzi® 01.09.01 Formulary Elafibranor  Iqirvo® 05.03.03.02 Formulary Elbasvir & grazoprevir Zepatier® 08.01.05 Formulary Elranatamab Elrexfio ® 05.03.01 Formulary Emtricitabine & Elvitegravir & Cobicistat & Tenofovir alafenamide Genvoya® 05.03.01 Formulary Emtricitabine & Rilpivirine & Tenofovir alafenamide Odefsey® 05.03.01 Formulary Emtricitabine & Rilpivirine & Tenofovir disoproxil Eviplera® 05.03.01 Formulary Emtricitabine & Tenofovir alafenamide Descovy® 05.03.01 Formulary Emtricitabine & Tenofovir Disoproxil  08.01.05 Formulary Encorafenib Braftovi® 08.01.05 Formulary Entrectinib Rozlytrek® 08.01.05 Formulary Epcoritamab Tepkinly® 04.12 Formulary Eplontersen  Wainzua ® 08.01.05 Formulary Eribulin Halaven® 02.11 Formulary Etranacogene dezaparvovec Hemgenix® 02.12 Formulary Evinacumab Evkeeza® 09.01 Formulary Exagamglogene Autotemcel Casgevy® 08.01.05 Formulary Fedratinib  04.08.01 Formulary Fenfluramine Fintepla® 08.02.04 Formulary Fingolimod  04.09.01 Formulary Foslevidopa/foscarbidopa  Produodopa® 05.03.01 Formulary Fostemsavir Rukobia® 08.01.05 Formulary Futibatinib Lytgobi ® 08.01.05 Formulary Gemtuzumab ozogamicin Mylotarg® 08.01.05 Formulary Gilteritinib Xospata® 08.02.04 Formulary Glatiramer Acetate  05.03.03.02 Formulary Glecaprevir & Pibrentasvir Maviret® 08.01.05 Formulary Glofitamab Columvi® 08.01.05 Formulary Ibrutinib Imbruvica® 03.04.03 Formulary Icatibant Firazyr® 08.01.05 Formulary Idelalisib   08.01.05 Formulary Imatinib   08.01.05 Formulary Imlifidase Idefirix® 04.12 Formulary Inotersen  Tegsedi® 08.01.05 Formulary Inotuzumab ozogamicin Besponsa® 08.02.04 Formulary Interferon Beta Avonex® 08.02.04 Formulary Interferon Beta Rebif® 08.02.04 Formulary Interferon Beta Betaferon® 08.02.04 Formulary Interferon beta Extavia® 08.01.05 Formulary Ipilimumab Yervoy® 09.01.03 Formulary Iptacopan Fabhalta® 08.01.05 Formulary Ivosidenib Tibsovo® 03.04.03 Formulary Lanadelumab Takhzyro® 08.01.05 Formulary Larotrectinib  08.02.04 Formulary Lenalidomide  08.01.05 Formulary Lenvatinib Kisplyx® 05.03.02.02 Formulary Letermovir Prevymis® 04.09.01 Formulary Levidopa/carbidopa Intestinal Gel Duodopa® 08.01.05 Formulary Loncastuximab tesirine Zynlonta® 08.01.05 Formulary Lorlatinib Lorviqua® 03.07 Formulary Lumacaftor and Ivacaftor Orkambi® 05.03.02.02 Formulary Maribavir Livtencity® 03.04.02 Formulary Mepolizumab Nucala® 06.08 Formulary Metreleptin  08.01.05 Formulary Midostaurin Rydapt® 08.01.05 Formulary Mobocertinib  08.01.05 Formulary Mogamulizumab  Poteligeo® 08.01.05 Formulary Momelotinib Omjjara® 08.02.04 Formulary Natalizumab  08.01.05 Formulary Neratinib Nerlynx® 08.01.05 Formulary Nilotinib Tasigna® 08.01.05 Formulary Niraparib Zejula® 08.01.05 Formulary Nivolumab  Opdivo® 08.01.05 Formulary Nivolumab-relatlimab Opdualag® 08.02.03 Formulary Obinutuzumab  08.02.03 Formulary Ocrelizumab  08.02.03 Formulary Ofatumumab  Kesimpta® 08.01.05 Formulary Olaparib  Lynparza® 03.04.02 Formulary Omalizumab Xolair® 08.03.04.01 Formulary Palbociclib Ibrance® 05.03.05 Formulary Palivizumab  08.01.05 Formulary Panobinostat   04.12 Formulary Patisiran Onpattro® 08.02.04 Formulary Peginterferon Beta-1a Plegridy® 08.01.05 Formulary Pembrolizumab  Keytruda® 08.01.05 Formulary Pertuzumab Perjeta® 08.01.05 Formulary Polatuzumab vedotin Polivy® 08.02.04 Formulary Ponesimod Ponvory® 08.01.05 Formulary Quizartinib Vanflyta® 03.04.02 Formulary Reslizumab Cinquil® 05.03.03.02 Formulary Ribavirin  08.03.04.01 Formulary Ribociclib Kisqali® 01.05.03 Formulary Risankizumab Skyrizi® 08.01.05 Formulary Rucaparib  08.01.05 Formulary Sacituzumab govitecan Trodelvy® 09.08.01 Formulary Sebelipase alfa Kanuma® 08.01.05 Formulary Selinexor Nexpovio® 08.01.05 Formulary Selumetinib Koselugo® 06.07 Formulary Setmelanotide Imcivree® 08.02.04 Formulary Siponimod Mayzent® 08.01 Formulary Sodium thiosulfate (anhydrous) Pedmarqsi® 05.03.03.02 Formulary Sofosbuvir Sovaldi® 05.03.03.02 Formulary Sofosbuvir & Ledipasvir  Harvoni® 05.03.03.02 Formulary Sofosbuvir & velpatasvir  Epclusa® 05.03.03.02 Formulary Sofosbuvir, Velpatasvir & Voxilaprevir  Vosevi® 08.01.05 Formulary Sunitinib  Sutent® 04.12 Formulary Tafamidis  Vyndaqel® 08.01.05 Formulary Talazoparib  Talzenna® 08.01.05 Formulary Talimogene laherparepvec  08.01.05 Formulary Teclistamab Tecvayli® 01.04.02 Formulary Teduglutide Revestive® 08.02 Formulary Tepotinib Tepmetko® 08.02.04 Formulary Teriflunomide  03.07 Formulary Tezacaftor and ivacaftor  Symkevi® 03.07 Formulary Tezacaftor with ivacaftor and elexacaftor Kaftrio® 03.04.02 Formulary Tezepelumab Tezspire® 08.01.05 Formulary Tisagenlecleucel  10.01.03 Formulary Tocilizumab RoActemra® 08.01.05 Formulary Trametinib   08.01.05 Formulary Trastuzumab deruxtecan Enhertu 08.01.03 Formulary Trifluridine and tipiracil  08.01.05 Formulary Tucatinib Tukysa® 08.02.03 Formulary Ublituximab  Briumvi® 09.01.03 Formulary Vadadustat Vafseo ® 10.02 Formulary Vamorolone Agamree® 09.08.01 Formulary Velmanase alfa Lamzede ® 08.01.05 Formulary Venetoclax Venclyxto® 08.02.02 Formulary Voclosporin  Lupkynis® 19 Formulary Volanesorsen  Waylivra® 04.12 Formulary Vutrisiran Amvuttra® 08.01.05 Formulary Zanubrutinib Brukinsa® 08.01.05 Non Formulary Zanubrutinib Brukinsa®

North East and North Cumbria